Mind + Muscle

technical minds + legal muscle


dig deep

Challenging and Defending Patents in the Country's Largest Venue ― the PTAB

  • 09.15.17
  • 11:30 a.m.

Life sciences companies are increasingly using IPRs and PGRs as part of their strategy to bring drugs to market.  This trend exists not only for generic drugs and biosimilars, but also for new innovator drugs that may implicate competitors' patents. During this session, director Eldora L. Ellison, Ph.D., will focus on issues that challengers and patent owners must take into consideration in bringing or defending against post-grant challenges before the U.S. Patent Trial and Appeal Board.

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.